National Drug Strategy
National Drug Strategy

National pharmacotherapy policy for people dependent on opioids

Print page  Decrease text size  Increase text size

These guidelines have been prepared to provide a broad policy context and framework for state and territory policies and guidelines that are concerned with the treatment of heroin dependence with methadone, buprenorphine and naltrexone.

Published by the Australian Government Department of Health and Ageing for National Drug Strategy
January 2007

For clinical matters associated with pharmacotherapy treatments, please refer to respective national clinical guidelines.

PDF printable version of National pharmacotherapy policy for people dependent on opioids (PDF 499 KB)

Page currency, Latest update: January, 2007

Help with accessing large documents

When accessing large documents (over 500 KB in size), it is recommended that the following procedure be used:

  1. Click the link with the RIGHT mouse button
  2. Choose "Save Target As.../Save Link As..." depending on your browser
  3. Select an appropriate folder on a local drive to place the downloaded file

Attempting to open large documents within the browser window (by left-clicking) may inhibit your ability to continue browsing while the document is opening and/or lead to system problems.

Help with accessing PDF documents

To view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. A number of PDF readers are available through the Australian Government Information Management Office (AGIMO) Web Guide website.